Anti-CCL2 (Carlumab) -MC-Vc-PAB-DMEA-PEG2-Duocarmycin SA
Anti-CCL2 (Carlumab) -MC-Vc-PAB-DMEA-PEG2-Duocarmycin SA is an antibody-drug conjugate (ADC) consisting of the humanized anti-CCL2 (chemokine ligand 2) antibody Carlumab conjugated with the linker MC-Vc-PAB-DMEA-PEG2 and the DNA alkylator Duocarmycin SA (HY-12456). Anti-CCL2 (Carlumab) -MC-Vc-PAB-DMEA-PEG2-Duocarmycin SA can be used in cancer research[1][2].
Product Specifications
UNSPSC
12352203
Target
ADC Payload; Antibiotic; Antibody-Drug Conjugates (ADCs) ; Apoptosis; CCR; DNA Alkylator/Crosslinker
Related Pathways
Antibody-drug Conjugate/ADC Related; Anti-infection; Apoptosis; Cell Cycle/DNA Damage; GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Anti-CCL2(Carlumab)-MC-Vc-PAB-DMEA-PEG2-DuocarmycinSA]
References & Citations
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
CCR2
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF594 conjugate, 0.1mg/mL
Ep-CAM / CD326 (VU-1D9), CF488A conjugate, 0.1mg/mL
